"If you’re trying to get clean, it needs to be as easy and stress free as possible."
While it has been broadly assumed that patients prefer tele-MOUD to in-person treatment, there has been minimal research in this area. Researchers at RAND Corporation wanted to fill this gap in knowledge. With a grant from the National Institute of Drug Abuse, RAND launched the first-ever study in 2021 to explore different aspects of the patient’s perspective comparing in-person to tele-MOUD treatment. As part of this study, RAND researchers conducted 20 interviews with Bicycle Health patients between March and May 2021.
The results of this study were published in the Journal of Addiction Medicine in 2022.
Ease-of-Use: Patients interviewed as part of this study expressed their satisfaction with how convenient or easy it is to use Bicycle Health’s tele-MOUD treatment platform.
Faster Intake: Nearly all of the patients interviewed shared their appreciation for how quickly Bicycle Health was able to initiate tele-MOUD treatment with them. This process can be much longer for in-person care.
Limited High-Risk Exposure: Participants in this study noted that Bicycle Health’s tele-MOUD platform allowed them to build a positive treatment community without facing in-person exposure to others with OUD.
Download the White Paper
"In 2021, we saw over 75,000 opioid-related deaths in the U.S. — yet less than 10% of people accessed treatment, usually due to stigma, lack of accessibility, and the cost of treatment. This descriptive review is a major validation of Bicycle Health’s innovative telehealth model as we work to bring effective OUD treatment to patients across the country, and ultimately help more people live fulfilling lives free from opioid addiction."